Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin: The development of a prediction model

George Dranitsaris, Daniel Rayson, Mark Vincent, Jose Chang, Karen Gelmon, David Sandor, Greg Reardon

Research output: Contribution to journal › Article › peer-review

31 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin: The development of a prediction model'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Nursing and Health Professions

Keyphrases